KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Non-Current Liabilities (2018 - 2025)

Guardant Health's Other Non-Current Liabilities history spans 8 years, with the latest figure at $127.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 37.64% year-over-year to $127.8 million; the TTM value through Dec 2025 reached $127.8 million, up 37.64%, while the annual FY2025 figure was $127.8 million, 37.64% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $127.8 million at Guardant Health, up from $94.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $127.8 million in Q4 2025 and bottomed at $1.7 million in Q1 2021.
  • The 5-year median for Other Non-Current Liabilities is $9.8 million (2023), against an average of $47.5 million.
  • The largest annual shift saw Other Non-Current Liabilities surged 959.39% in 2024 before it decreased 4.97% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $3.9 million in 2021, then surged by 133.38% to $9.2 million in 2022, then skyrocketed by 945.93% to $96.0 million in 2023, then decreased by 3.3% to $92.8 million in 2024, then surged by 37.64% to $127.8 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Other Non-Current Liabilities are $127.8 million (Q4 2025), $94.4 million (Q3 2025), and $91.2 million (Q2 2025).